Scott A Canute - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Scott A Canute made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 145,385 shares made by Michel Dahan , a net sale of 100,765 shares made by Steven Keith Burke , and a net sale of 96,282 shares made by Nicole R. Hadas .

In summary, during the past 3 months, insiders sold 132,629 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 132,629 shares. During the past 18 months, 635,551 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 635,551 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Scott A Canute made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 15,473 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Scott A Canute made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 368,671 shares made by Jeff Evanson , a net sale of 520,000 shares made by Terry Dagnon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,006 shares, with a net purchase of 5,006 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 42,552 shares.

Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Scott A Canute made no insider transaction in Eli Lilly and Co (LLY). Other recent insider transactions involving Eli Lilly and Co (LLY) include a net sale of 3,779,086 shares made by Lilly Endowment Inc , a net sale of 3,220 shares made by Donald A Zakrowski , and a net sale of 2,148 shares made by Alonzo Weems .

In summary, during the past 3 months, insiders sold 398,671 shares of Eli Lilly and Co (LLY) in total and bought 0 shares, with a net sale of 398,671 shares. During the past 18 months, 3,795,454 shares of Eli Lilly and Co (LLY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,795,454 shares.

Eli Lilly and Co (LLY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Scott A Canute made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.